FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection

Yeztugo has shown over 99% effectiveness in trials, surpassing daily PrEP pill Truvada.

FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection.

FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection.

(photo credit: Anamaria Mejia. Via Shutterstock)

ByJERUSALEM POST STAFF

JUNE 21, 2025 14:15

RECOMMENDED STORIES

Smoke rises following an Israeli attack in Tehran, Iran, June 18, 2025.

IDF symbolically strikes in Tehran after Trump orders Netanyahu to turn planes around

JUNE 24, 2025

Iranian missile falls in Southern Negev.

Five killed, at least 20 wounded as Iran fires missile salvo at Israel

JUNE 24, 2025

Former Hamas leader Yahya Sinwar looks on at an anti-Israel rally, in Gaza City, in 2022.

Hamas leaders' October 7 letter reveals attack strategy and plea to Hezbollah

JUNE 24, 2025

Iran's Foreign Minister Abbas Araghchi speaks in Baghdad, Iraq October 13, 2024.

Iran's FM claims Tehran stopped attacks after Trump announces ceasefire with Israel

JUNE 23, 2025

Hot Opinion

Iran is not finished but Israel has bought itself crucial time

ByJPOST EDITORIAL

Jpost_Image

Operation Rising Lion has achieved its goals. So why do we feel so lousy?

Netanyahu, learn from Trump, sometimes you just have to do the right thing

Take the win: Why Israel should take Trump's ceasefire with Iran